1. Home
  2. INSM vs TTWO Comparison

INSM vs TTWO Comparison

Compare INSM & TTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$176.09

Market Cap

41.2B

Sector

Health Care

ML Signal

HOLD

Logo Take-Two Interactive Software Inc.

TTWO

Take-Two Interactive Software Inc.

HOLD

Current Price

$251.16

Market Cap

47.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSM
TTWO
Founded
1988
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
41.2B
47.2B
IPO Year
2000
1997

Fundamental Metrics

Financial Performance
Metric
INSM
TTWO
Price
$176.09
$251.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
20
Target Price
$185.84
$269.25
AVG Volume (30 Days)
3.8M
1.3M
Earning Date
02-19-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$447,022,000.00
$6,219,900,000.00
Revenue This Year
$43.95
$17.42
Revenue Next Year
$130.35
$38.08
P/E Ratio
N/A
N/A
Revenue Growth
30.34
13.98
52 Week Low
$60.40
$177.35
52 Week High
$212.75
$264.79

Technical Indicators

Market Signals
Indicator
INSM
TTWO
Relative Strength Index (RSI) 39.45 53.55
Support Level $173.24 $240.28
Resistance Level $179.44 $260.04
Average True Range (ATR) 5.92 4.29
MACD -1.75 0.89
Stochastic Oscillator 32.48 55.01

Price Performance

Historical Comparison
INSM
TTWO

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About TTWO Take-Two Interactive Software Inc.

Take-Two is one of the largest global developers and publishers of video games, with labels including Rockstar, 2K, and Zynga. Grand Theft Auto is the firm's biggest franchise, accounting for about 30% of total sales for the past decade. NBA 2K is the industry's dominant basketball video game, with Take-Two releasing a new version annually. Other notable franchises include Red Dead Redemption, Borderlands, and Civilization. Typically, more than three-fourths of the firm's sales are from in-game spending, with the remainder coming from initial game sales. Since acquiring Zynga in 2022, mobile makes up about half of total sales.

Share on Social Networks: